Boston Scientific
633 hedge funds and large institutions have $34.3B invested in Boston Scientific in 2018 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 201 increasing their positions, 229 reducing their positions, and 67 closing their positions.
18% more call options, than puts
Call options by funds: $78.9M | Put options by funds: $66.8M
10% more capital invested
Capital invested by funds: $31B → $34.3B (+$3.22B)
8% more funds holding in top 10
Funds holding in top 10: 13 → 14 (+1)
7% more first-time investments, than exits
New positions opened: 72 | Existing positions closed: 67
0% more funds holding
Funds holding: 632 → 633 (+1)
0.08% more ownership
Funds ownership: 91.15% → 91.23% (+0.08%)
12% less repeat investments, than reductions
Existing positions increased: 201 | Existing positions reduced: 229
Top Buyers
| 1 |
Millennium Management
New York
|
+$240M |
| 2 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$231M |
| 3 |
BlackRock
New York
|
+$231M |
| 4 |
SIG
Senator Investment Group
New York
|
+$224M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$182M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$424M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$170M |
| 3 |
State Street
Boston,
Massachusetts
|
-$148M |
| 4 |
JP Morgan Chase
New York
|
-$146M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$145M |
BSX Hedge Fund Activity: Q1 2018 in Review
633 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2018, worth a combined $34.3B — up 10% from $31B a quarter earlier.
Buyers outnumbered sellers: 72 funds opened new BSX positions and 67 closed out — a net gain of 5 holders — while 201 added to existing stakes and 229 trimmed.
The largest buyer was Millennium Management, adding an estimated $240M. The largest seller was Fidelity Investments, cutting an estimated $424M.
- 633 institutional investors held Boston Scientific (BSX) as of Q1 2018, up from 632 in Q4 2017.
- Funds reported $34.3B of Boston Scientific stock for Q1 2018, up 10% quarter-over-quarter.
- 72 funds opened new Boston Scientific positions in Q1 2018 and 67 closed out, a net change of +5 holders.
- The largest Boston Scientific buyer in Q1 2018 was Millennium Management, an estimated $240M added.
- The largest Boston Scientific seller in Q1 2018 was Fidelity Investments, an estimated $424M sold.
Based on aggregated 13F filings for Q1 2018.